Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Comparison of long-term immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine in healthy women aged 18-45 years: end-of-study analysis of a Phase III randomized trial.

Einstein MH, Takacs P, Chatterjee A, Sperling RS, Chakhtoura N, Blatter MM, Lalezari J, David MP, Lin L, Struyf F, Dubin G; HPV-010 Study Group.

Hum Vaccin Immunother. 2014;10(12):3435-45. doi: 10.4161/hv.36121.

2.

Milk protein-based infant formula containing rice starch and low lactose reduces common regurgitation in healthy term infants: a randomized, blinded, and prospective trial.

Lasekan JB, Linke HK, Oliver JS, Carver JD, Blatter MM, Kuchan MJ, Cramer JM, Pollack PF.

J Am Coll Nutr. 2014;33(2):136-46. doi: 10.1080/07315724.2013.828578. Review.

PMID:
24724771
3.

Safety and immunogenicity of a quadrivalent inactivated influenza vaccine compared to licensed trivalent inactivated influenza vaccines in adults.

Greenberg DP, Robertson CA, Noss MJ, Blatter MM, Biedenbender R, Decker MD.

Vaccine. 2013 Jan 21;31(5):770-6. doi: 10.1016/j.vaccine.2012.11.074. Epub 2012 Dec 8.

PMID:
23228813
4.

Immunogenicity and safety of two tetravalent (measles, mumps, rubella, varicella) vaccines coadministered with hepatitis a and pneumococcal conjugate vaccines to children twelve to fourteen months of age.

Blatter MM, Klein NP, Shepard JS, Leonardi M, Shapiro S, Schear M, Mufson MA, Martin JM, Varman M, Grogg S, London A, Cambron P, Douha M, Nicholson O, da Costa C, Innis BL.

Pediatr Infect Dis J. 2012 Aug;31(8):e133-40. doi: 10.1097/INF.0b013e318259fc8a.

PMID:
22622699
5.

Immunogenicity and safety of human papillomavirus-16/18 AS04-adjuvanted vaccine coadministered with tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine and/or meningococcal conjugate vaccine to healthy girls 11 to 18 years of age: results from a randomized open trial.

Wheeler CM, Harvey BM, Pichichero ME, Simon MW, Combs SP, Blatter MM, Marshall GS, Catteau G, Dobbelaere K, Descamps D, Dubin G, Schuind A.

Pediatr Infect Dis J. 2011 Dec;30(12):e225-34. doi: 10.1097/INF.0b013e31822d28df.

PMID:
21817954
6.

Lactose-free milk protein-based infant formula: impact on growth and gastrointestinal tolerance in infants.

Lasekan JB, Jacobs J, Reisinger KS, Montalto MB, Frantz MP, Blatter MM.

Clin Pediatr (Phila). 2011 Apr;50(4):330-7. doi: 10.1177/0009922810390511.

PMID:
21436148
7.

Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6.4 years.

GlaxoSmithKline Vaccine HPV-007 Study Group, Romanowski B, de Borba PC, Naud PS, Roteli-Martins CM, De Carvalho NS, Teixeira JC, Aoki F, Ramjattan B, Shier RM, Somani R, Barbier S, Blatter MM, Chambers C, Ferris D, Gall SA, Guerra FA, Harper DM, Hedrick JA, Henry DC, Korn AP, Kroll R, Moscicki AB, Rosenfeld WD, Sullivan BJ, Thoming CS, Tyring SK, Wheeler CM, Dubin G, Schuind A, Zahaf T, Greenacre M, Sgriobhadair A.

Lancet. 2009 Dec 12;374(9706):1975-85. doi: 10.1016/S0140-6736(09)61567-1.

PMID:
19962185
8.
9.

The pediatrician's role in preventing cervical cancer.

Blatter MM, Monk BJ.

Clin Pediatr (Phila). 2008 Sep;47(7):627-38. doi: 10.1177/0009922808315219. Review. No abstract available.

PMID:
18698095
10.

Immunogenicity and safety of an inactivated hepatitis a vaccine administered concomitantly with a pneumococcal conjugate vaccine in healthy children 15 months of age.

Trofa AF, Levin M, Marchant CD, Hedrick J, Blatter MM.

Pediatr Infect Dis J. 2008 Jul;27(7):658-60. doi: 10.1097/INF.0b013e31816907bd.

PMID:
18536623
12.
13.

Immunogenicity and safety of an inactivated hepatitis A vaccine administered concomitantly with diphtheria-tetanus-acellular pertussis and haemophilus influenzae type B vaccines to children less than 2 years of age.

Nolan T, Bernstein H, Blatter MM, Bromberg K, Guerra F, Kennedy W, Pichichero M, Senders SD, Trofa A, Collard A, Sullivan DC, Descamps D.

Pediatrics. 2006 Sep;118(3):e602-9.

PMID:
16950952
14.

Acellular pertussis vaccine booster combined with diphtheria and tetanus toxoids for adolescents.

Pichichero ME, Blatter MM, Kennedy WA, Hedrick J, Descamps D, Friedland LR.

Pediatrics. 2006 Apr;117(4):1084-93.

PMID:
16585302
15.

Combined tetanus, diphtheria, and 5-component pertussis vaccine for use in adolescents and adults.

Pichichero ME, Rennels MB, Edwards KM, Blatter MM, Marshall GS, Bologa M, Wang E, Mills E.

JAMA. 2005 Jun 22;293(24):3003-11. Epub 2005 Jun 2. Erratum in: JAMA. 2005 Dec 28;294(24):3092.

PMID:
15933223
16.

A bovine parainfluenza virus type 3 vaccine is safe and immunogenic in early infancy.

Greenberg DP, Walker RE, Lee MS, Reisinger KS, Ward JI, Yogev R, Blatter MM, Yeh SH, Karron RA, Sangli C, Eubank L, Coelingh KL, Cordova JM, August MJ, Mehta HB, Chen W, Mendelman PM.

J Infect Dis. 2005 Apr 1;191(7):1116-22. Epub 2005 Feb 22.

PMID:
15747247
17.

Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial.

Harper DM, Franco EL, Wheeler C, Ferris DG, Jenkins D, Schuind A, Zahaf T, Innis B, Naud P, De Carvalho NS, Roteli-Martins CM, Teixeira J, Blatter MM, Korn AP, Quint W, Dubin G; GlaxoSmithKline HPV Vaccine Study Group.

Lancet. 2004 Nov 13-19;364(9447):1757-65.

PMID:
15541448
18.

High-dose, short-duration, early valacyclovir therapy for episodic treatment of cold sores: results of two randomized, placebo-controlled, multicenter studies.

Spruance SL, Jones TM, Blatter MM, Vargas-Cortes M, Barber J, Hill J, Goldstein D, Schultz M.

Antimicrob Agents Chemother. 2003 Mar;47(3):1072-80.

19.

Impact of a birth dose of hepatitis B vaccine on the reactogenicity and immunogenicity of diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b combination vaccination.

Pichichero ME, Blatter MM, Reisinger KS, Harrison CJ, Johnson CE, Steinhoff MC, Senders SD, Rothstein EP, Willems P, Howe BJ.

Pediatr Infect Dis J. 2002 Sep;21(9):854-9.

PMID:
12352809
20.

Oral pleconaril treatment of picornavirus-associated viral respiratory illness in adults: efficacy and tolerability in phase II clinical trials.

Hayden FG, Coats T, Kim K, Hassman HA, Blatter MM, Zhang B, Liu S.

Antivir Ther. 2002 Mar;7(1):53-65.

PMID:
12008788
21.

Interchangeability of 2 diphtheria-tetanus-acellular pertussis vaccines in infancy.

Greenberg DP, Pickering LK, Senders SD, Bissey JD, Howard RA, Blatter MM, Reisinger K, Pichichero ME, Howe BJ.

Pediatrics. 2002 Apr;109(4):666-72.

PMID:
11927713
22.

Immune status of infants fed soy-based formulas with or without added nucleotides for 1 year: part 2: immune cell populations.

Cordle CT, Winship TR, Schaller JP, Thomas DJ, Buck RH, Ostrom KM, Jacobs JR, Blatter MM, Cho S, Gooch WM 3rd, Pickering LK.

J Pediatr Gastroenterol Nutr. 2002 Feb;34(2):145-53.

PMID:
11840031
23.

Immune status of infants fed soy-based formulas with or without added nucleotides for 1 year: part 1: vaccine responses, and morbidity.

Ostrom KM, Cordle CT, Schaller JP, Winship TR, Thomas DJ, Jacobs JR, Blatter MM, Cho S, Gooch WM 3rd, Granoff DM, Faden H, Pickering LK.

J Pediatr Gastroenterol Nutr. 2002 Feb;34(2):137-44.

PMID:
11840030
24.

Antibody responses to bovine parainfluenza virus type 3 (PIV3) vaccination and human PIV3 infection in young infants.

Lee MS, Greenberg DP, Yeh SH, Yogev R, Reisinger KS, Ward JI, Blatter MM, Cho I, Holmes SJ, Cordova JM, August MJ, Chen W, Mehta HB, Coelingh KL, Mendelman PM.

J Infect Dis. 2001 Oct 1;184(7):909-13. Epub 2001 Aug 15.

PMID:
11509996
25.

Safety and immunogenicity of four doses of Neisseria meningitidis group C vaccine conjugated to CRM197 in United States infants.

Rennels MB, Edwards KM, Keyserling HL, Reisinger K, Blatter MM, Quataert SA, Madore DV, Chang I, Malinoski FJ, Hackell JG, Paradiso PR.

Pediatr Infect Dis J. 2001 Feb;20(2):153-9.

PMID:
11224833
26.

Reply

Frey S, Dagan R, Ashur Y, Chen XQ, Ibarra J, Kollaritsch H, Mazur MH, Poland GA, Reisinger K, Walter E, Van Damme P, Braconier JH, Uhnoo I I, Wahl M, Blatter MM, Clements D, Greenberg D, Jacobson RM, Norrby SR, Rowe M, Shouval D, Simmons SS, van Hattum J, Wennerholm S, O'Brien Gress J, Chan I I.

J Infect Dis. 2000 Sep;182(3):1005-6. No abstract available.

PMID:
10950808
27.

Interference of antibody production to hepatitis B surface antigen in a combination hepatitis A/hepatitis B vaccine.

Frey S, Dagan R, Ashur Y, Chen XQ, Ibarra J, Kollaritsch H, Mazur MH, Poland GA, Reisinger K, Walter E, Van Damme P, Braconier JH, Uhnoo I, Wahl M, Blatter MM, Clements D, Greenberg D, Jacobson RM, Norrby SR, Rowe M, Shouval D, Simmons SS, van Hattum J, Wennerholm S, Gress JO, et al.

J Infect Dis. 1999 Dec;180(6):2018-22. Erratum in: J Infect Dis 2000 Feb;181(2):814.

PMID:
10558961
28.

Growth of newborn, term infants fed soy formulas for 1 year.

Lasekan JB, Ostrom KM, Jacobs JR, Blatter MM, Ndife LI, Gooch WM 3rd, Cho S.

Clin Pediatr (Phila). 1999 Oct;38(10):563-71. Review.

PMID:
10544862
29.

An acellular pertussis vaccine in healthy adults: safety and immunogenicity. Pennridge Pediatric Associates.

Rothstein EP, Anderson EL, Decker MD, Poland GA, Reisinger KS, Blatter MM, Jacobson RM, Mink CA, Gennevois D, Izu AE, Sinangil F, Langenberg AG.

Vaccine. 1999 Aug 6;17(23-24):2999-3006.

PMID:
10462235
30.

Comparison of acellular pertussis-diphtheria-tetanus toxoids and Haemophilus influenzae type b vaccines administered separately vs. combined in younger vs. older toddlers.

Rennels MB, Hohenboken MJ, Reisinger KS, Clements DA, Walter EB Jr, Blatter MM, Nonenmacher J, Hackell JG.

Pediatr Infect Dis J. 1998 Feb;17(2):164-6. No abstract available.

PMID:
9493818
31.

Reactogenicity and immunogenicity of a three-component acellular pertussis vaccine administered as the primary series to 2, 4 and 6 month old infants in the United States.

Bernstein HH, Rothstein EP, Pichichero ME, Green JL, Reisinger KS, Blatter MM, Halpern J, Arbeter AM, Bernstein DI, Smith V, et al.

Vaccine. 1995 Dec;13(17):1631-5.

PMID:
8719512
32.

Comparison of a three-component acellular pertussis vaccine with a whole-cell pertussis vaccine in 4- through 6-year-old children. Elmwood Pediatric Associates, Pennridge Pediatric Associates.

Annunziato PW, Rothstein EP, Bernstein HH, Blatter MM, Reisinger KS, Pichichero ME.

Arch Pediatr Adolesc Med. 1994 May;148(5):503-7.

PMID:
8180641
33.

Comparison of a three-component acellular pertussis vaccine with a whole-cell pertussis vaccine in 15- through 20-month-old infants.

Bernstein HH, Rothstein EP, Reisinger KS, Blatter MM, Arbeter AM, Fontana ME, Jacobs JM, Long SS, Rathfon H, Crayne O, et al.

Pediatrics. 1994 Apr;93(4):656-9.

PMID:
8134224
34.

Clinical survey of natural varicella compared with breakthrough varicella after immunization with live attenuated Oka/Merck varicella vaccine.

Bernstein HH, Rothstein EP, Watson BM, Reisinger KS, Blatter MM, Wellman CO, Chartrand SA, Cho I, Ngai A, White CJ.

Pediatrics. 1993 Dec;92(6):833-7.

PMID:
8233746
35.

Safety and immunogenicity of a combined diphtheria, tetanus, pertussis and Haemophilus influenzae type b vaccine in young infants.

Paradiso PR, Hogerman DA, Madore DV, Keyserling H, King J, Reisinger KS, Blatter MM, Rothstein E, Bernstein HH, Hackell J.

Pediatrics. 1993 Dec;92(6):827-32.

PMID:
8233745
36.

Immunogenicity of Haemophilus influenzae type b polysaccharide-tetanus toxoid conjugate vaccine in infants.

Holmes SJ, Fritzell B, Guito KP, Esbenshade JF, Blatter MM, Reisinger KS, Keyserling HL, Rothstein EP, Bernstein HH, Feldman S, et al.

Am J Dis Child. 1993 Aug;147(8):832-6.

PMID:
8352217
37.

Comparative study of sultamicillin and amoxicillin-clavulanate: treatment of acute otitis media.

Chan KH, Bluestone CD, Tan LS, Reisinger KS, Blatter MM, Fall PA.

Pediatr Infect Dis J. 1993 Jan;12(1):24-8.

PMID:
8417421
38.

Acellular pertussis vaccination of 2-month-old infants in the United States.

Pichichero ME, Francis AB, Blatter MM, Reisinger KS, Green JL, Marsocci SM, Disney FA.

Pediatrics. 1992 May;89(5 Pt 1):882-7.

PMID:
1579399
39.

Immunogenicity of subcutaneous versus intramuscular Oka/Merck varicella vaccination in healthy children.

Dennehy PH, Reisinger KS, Blatter MM, Veloudis BA.

Pediatrics. 1991 Sep;88(3):604-7.

PMID:
1881743
40.

Amoxicillin or myringotomy or both for acute otitis media: results of a randomized clinical trial.

Kaleida PH, Casselbrant ML, Rockette HE, Paradise JL, Bluestone CD, Blatter MM, Reisinger KS, Wald ER, Supance JS.

Pediatrics. 1991 Apr;87(4):466-74.

PMID:
2011422
41.

Comparison of an acellular pertussis-component diphtheria-tetanus-pertussis (DTP) vaccine with a whole-cell pertussis-component DTP vaccine in 17- to 24-month-old children, with measurement of 69-kilodalton outer membrane protein antibody.

Blumberg DA, Mink CM, Cherry JD, Reisinger KS, Blatter MM, Congeni BL, Dekker CL, Stout MG, Mezzatesta JR, Scott JV, et al.

J Pediatr. 1990 Jul;117(1 Pt 1):46-51.

PMID:
2196360
42.

Comparison of acellular and whole-cell pertussis-component DTP vaccines. A multicenter double-blind study in 4- to 6-year-old children.

Morgan CM, Blumberg DA, Cherry JD, Reisinger KS, Blatter MM, Blumer JL, Dekker CL, Stout MG, Christenson PD.

Am J Dis Child. 1990 Jan;144(1):41-5.

PMID:
2403747
43.

A comparative study of amoxicillin-clavulanate and amoxicillin. Treatment of otitis media with effusion.

Chan KH, Mandel EM, Rockette HE, Bluestone CD, Bass LW, Blatter MM, Breck JM, Reisinger KS, Wolfson JH, Wucher FP, et al.

Arch Otolaryngol Head Neck Surg. 1988 Feb;114(2):142-6.

PMID:
3276343
44.

Cefixime vs. cefaclor in the treatment of acute otitis media in infants and children.

Kenna MA, Bluestone CD, Fall P, Stephenson J, Kurs-Lasky M, Wucher FP, Blatter MM, Reisinger KS.

Pediatr Infect Dis J. 1987 Oct;6(10):992-6. No abstract available.

PMID:
3696840
45.

Sultamicillin (ampicillin-sulbactam) in the treatment of acute otitis media in children.

Kaleida PH, Bluestone CD, Blatter MM, Reisinger KS, Wucher FP, Fall PA, Rohn DD.

Pediatr Infect Dis. 1986 Jan-Feb;5(1):33-8.

PMID:
3003716
46.

Comparison of bacampicillin and amoxicillin in acute otitis media with effusion.

Kim HK, Bluestone CD, Blatter MM, Reisinger KS, Wucher FP, Rohn DD, Fall P, Digaudio K, Rebholz L.

Bull N Y Acad Med. 1983 Jun;59(5):515-23. No abstract available.

47.

Quantitative cultures of middle-ear fluid in acute otitis media.

Wald ER, Rohn DD, Chiponis DM, Blatter MM, Reisinger KS, Wucher FP.

J Pediatr. 1983 Feb;102(2):259-61. No abstract available.

PMID:
6822934
48.

Duration of effusion after antibiotic treatment for acute otitis media: comparison of cefaclor and amoxicillin.

Mandel EM, Bluestone CD, Rockette HE, Blatter MM, Reisinger KS, Wucher FP, Harper J.

Pediatr Infect Dis. 1982 Sep-Oct;1(5):310-6.

PMID:
6760146
49.

Pediatric counseling and subsequent use of smoke detectors.

Miller RE, Reisinger KS, Blatter MM, Wucher F.

Am J Public Health. 1982 Apr;72(4):392-3.

Supplemental Content

Loading ...
Support Center